Skip to main content
Retour
Watch Compare

SINOVAC BIOTECH LTD

Qualité des données : 100%
SVA
Nasdaq Manufacturing Chemicals
6,47 €
0,00 € (0,00%)
Cap. Boursière: 642,44 M
Prix
6,47 €
Cap. Boursière
642,44 M
Fourchette du Jour
6,47 € — 6,47 €
Fourchette 52 Semaines
6,47 € — 6,47 €
Volume
0
Ouverture 0,00 €
Moyenne 50J / 200J
6,47 €
0,00% above
Moyenne 50J / 200J
6,47 €
0,00% above

Quick Summary

Points Clés

Revenue grew 16,18% annually over 5 years — strong growth
Earnings declined -187,75% over the past year
Debt/Equity of 0,03 — conservative balance sheet
Generating 104,00 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 86,15%

Croissance

Revenue Growth (5Y)
16,18%
Au-dessus de la moyenne du secteur (9,35%)
Revenue (1Y)-69,97%
Earnings (1Y)-187,75%
FCF Growth (3Y)-91,57%

Qualité

Return on Equity
-1,13%
Au-dessus de la moyenne du secteur (-51,02%)
ROIC-3,73%
Net Margin-22,29%
Op. Margin-134,52%

Sécurité

Debt / Equity
0,03
En dessous de la moyenne du secteur (0,33)
Current Ratio10,31
Interest Coverage-266,82

Valorisation

PE (TTM)
-6,43
En dessous de la moyenne du secteur (-1,98)
P/B Ratio0,07
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (44 pairs)
Métrique Action Médiane du Secteur
P/E -6,4 -2,0
P/B 0,1 5,1
ROE % -1,1 -51,0
Net Margin % -22,3 -150,2
Rev Growth 5Y % 16,2 9,3
D/E 0,0 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -69,97% Revenue Growth (3Y) -84,79%
Earnings Growth (1Y) -187,75% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 16,18% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 448,27 M Net Income (TTM) -99,92 M
ROE -1,13% ROA -0,72%
Gross Margin 59,51% Operating Margin -134,52%
Net Margin -22,29% Free Cash Flow (TTM) 104,00 M
ROIC -3,73% FCF Growth (3Y) -91,57%
Safety
Debt / Equity 0,03 Current Ratio 10,31
Interest Coverage -266,82 Asset Turnover 0,03
Working Capital 10,68 B Tangible Book Value 8,70 B
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6,43 Forward P/E N/A
P/B Ratio 0,07 P/S Ratio 1,43
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 16,19%
Market Cap 642,44 M Enterprise Value -373,79 M
Per Share
EPS (Diluted TTM) -1,06 Revenue / Share 4,51
FCF / Share 1,05 OCF / Share 1,05
EPS CAGR (1Y) -206,00% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -104,08%
SBC-Adj. FCF 104,00 M Growth Momentum -86,15

Income Statement

Annual, most recent first
Metric FY2023 FY2022 FY2021 FY2020 FY2019
Revenue 448,27 M 1,49 B 19,37 B 510,62 M 246,05 M
Net Income -99,92 M 113,87 M 8,47 B 110,37 M 44,93 M
EPS (Diluted) -1,06 1,00 74,27 0,97 0,41
Gross Profit 266,75 M 808,31 M 18,30 B 443,44 M 213,58 M
Operating Income -603,02 M -466,07 M 17,55 B 215,64 M 68,56 M
EBITDA — — — — —
R&D Expenses 344,52 M 442,11 M 155,04 M 48,76 M 24,25 M
SG&A Expenses 466,32 M 823,54 M 591,17 M 176,53 M 121,47 M
D&A — — — — —
Interest Expense 2,26 M 1,26 M 2,84 M 1,45 M 650 000,0
Income Tax 105,32 M -62,89 M 3,10 B 31,44 M 5,61 M

Balance Sheet

Annual, most recent first
Metric FY2023 FY2022 FY2021 FY2020 FY2019
Total Assets 13,66 B 14,11 B 16,75 B 1,90 B 452,30 M
Total Liabilities 1,64 B 1,40 B 2,87 B 781,20 M 100,10 M
Shareholders' Equity 8,71 B 8,92 B 9,33 B 746,47 M 294,02 M
Total Debt 253,91 M 11,81 M 15,77 M 35,10 M 5,93 M
Cash & Equivalents 1,27 B 4,28 B 11,61 B 1,04 B 152,72 M
Current Assets 11,83 B 12,13 B 14,92 B 1,56 B 349,61 M
Current Liabilities 1,15 B 1,09 B 2,41 B 679,61 M 87,20 M